Difference in coronary artery intima and media calcification in autopsied patients with chronic kidney disease

Clinical Nephrology

Volumn 75, Issue 1, 2011, Pages 1-7

  Yoshida, H ^a   Yokoyama, K ^a   Yaginuma, T ^a   Ohkido, I ^a   Yamamoto, H ^a   Utsunomiya, Y ^a   Kawakami, M ^b   Hosoya, T ^a  

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Seirei Sakura Citizen Hospital   (Japan)

Author keywords

Autopsy; Chronic kidney disease; Coronary artery calcification; Macrophages; Vascular smooth muscle cells

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CD68 ANTIGEN; OSTEOPONTIN; TRANSCRIPTION FACTOR RUNX2;

ARTERY CALCIFICATION; ARTERY MEDIA; ARTICLE; AUTOPSY; CHRONIC KIDNEY DISEASE; CORONARY ARTERY; CORONARY ARTERY CALCIFICATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTIMA; MACROPHAGE; VASCULAR SMOOTH MUSCLE;

ACTINS; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; AUTOPSY; BIOLOGICAL MARKERS; CALCINOSIS; CHRONIC DISEASE; CORE BINDING FACTOR ALPHA 1 SUBUNIT; CORONARY ARTERY DISEASE; CORONARY VESSELS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY DISEASES; MACROPHAGES; MALE; MIDDLE AGED; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; OSTEOPONTIN; RENAL DIALYSIS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TUNICA INTIMA; TUNICA MEDIA;

EID: 79251511247     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.2379/CN106401     Document Type: Article

References (30)

1. Foley RN, Parfrey PS, Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis. 1998; 32: 112-119.
2. Shanahan CM. Mechanisms of vascular calcification in renal disease. Clin Nephrol. 2005; 63: 146-157.
3. London GM, Guerin AP, Marchais SJ, Métivier F, Pan nier B, Adda H. Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality. Nephrol Dial Trans plant. 2003; 18: 1731-1740.
4. Goodman WG, London G, Amann K et al. Vascular calcification in chronic kidney disease. Am J Kidney Dis. 2004; 43: 572-579.
5. Berliner JA, Navab M, Fogelman AM, et al. Circulation. Atherosclerosis: basic mechanisms. Oxidation, inflammation, and genetics. Circulation. 1995; 91: 2488-2496.
6. Lehto S, Niskanen L, Suhonen M, Rönnemaa T, Laakso M. Medial artery calcification. A neglected harbinger of cardiovascular complications in noninsulin-dependent diabetes mellitus: Arterioscler Thromb Vasc Biol. 1996; 16: 978-983.
7. Goodman WG, London G, Amann K, et al. Vascular Calcification Work Group. Vascular calcification in chronic kidney disease. Am J Kidney Dis. 2004; 43: 572-579.
8. Shanahan CM, Cary NR, Salisbury JR, Proudfoot D, Weissberg PL, Edmonds ME. Medial localization of mineralization-regulating proteins in association with Mönckeberg's sclerosis: evidence for smooth muscle cell-mediated vascular calcification. Circulation. 1999; 100: 2168-2176.
9. Shanahan CM, Cary NR, Salisbury JR, et al. Medial localization of mineralization-regulating proteins in association with Mönckeberg's sclerosis: evidence for smooth muscle cell-mediated vascular calcification. Circulation. 1999; 100: 2168-2176.
10. Moe SM, Duan D, Doehle BP, et al. Uremia induces the osteoblast differentiation factor Cbfa1 in human blood vessels. Kidney Int. 2003; 63: 1003-1011. (Pubitemid 36315578)
11. Otto F, Thornell AP, Crompton T, et al. Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell. 1997; 89: 765-771.
12. Demer LL. Vascular calcification and osteoporosis: in flammatory responses to oxidized lipids. Int J Epidemiol. 2002; 31: 737-741.
13. Oh J, Wunsch R, Turzer M, et al. Advanced coronary and carotid arteriopathy in young adults with childhood-onset chronic renal failure. Circulation. 2002; 106: 100-105.
14. Tintut Y, Patel J, Territo M, Saini T, Parhami F, Demer LL. Monocyte/macrophage regulation of vascular calcification in vitro. Circulation. 2002; 105: 650-655.
15. Tintut Y, Patel J, Parhami F, Demer LL. Tumor necrosis factor-α promotes in vitro calcification of vascular cells via the cAMP pathway. Circulation. 2000; 102: 2636-2642.
16. Schoppet M, Shroff RC, Hofbauer LC et al. Exploring the biology of vascular calcification in chronic kidney disease: what's circulating? Kidney Int. 2008; 73: 384-390.
17. Moe SM, O'Neill KD, Duan D, et al. Medial artery calcification in ESRD patients is associated with deposition of bone matrix proteins. Kidney Int. 2002; 61: 638-647. (Pubitemid 34102607)
18. Proudfoot D, Skepper JN, Hegyi L, Bennett MR, Shanahan CM, Weissberg PL. Apoptosis regulates human vascular calcification in vitro: evidence for initiation of vascular calcification by apoptotic bodies. Circ Res. 2000; 87: 1055-1062.
19. Moe SM, Chen NX. Pathophysiology of vascular calcification in chronic kidney disease. Circ Res. 2004; 95: 560-567. (Pubitemid 39274370)
20. Imai E, Horio M, Nitta K, Yamagata K, Iseki K, Tsukamoto Y, Ito S, Makino H, Hishida A, Matsuo S. Modification of the Modification of Diet in Renal Disease (MDRD) Study equation for Japan. Am J Kidney Dis. 2007; 50: 927-937. (Pubitemid 350130278)
21. Falini B, Flenghi L, Pileri S et al. PG-M1: A new monoclonal antibody directed against a fixative-resistant epitope on the macrophage-restricted form of the CD68 molecule. Am J Pathol. 1993; 142: 1359-1372.
22. Scatena M, Liaw L, Giachelli CM et al. Osteo pontin: a multifunctional molecule regulating chronic inflammation and vascular disease. Arterioscler Thromb Vasc Biol. 2007; 27: 2302-2309.
23. Nitta K, Ishizuka T, Horita S, et al. Soluble osteopontin and vascular calcification in hemodialysis patients. Nephron. 2001; 89: 455-458.
24. Giachelli CM, Jono S, Shioi A, Nishizawa Y, Mori K, Morii H. Vascular calcification and inorganic phosphate. Am J Kidney Dis. 2001; 38: 34-37.
25. Wada T, McKee MD, Steitz S et al. Calcification of vascular smooth muscle cell cultures: Inhibition by osteopontin. Circ Res. 1999; 84: 166-178.
26. Jono S, Peinado C, Giachelli CM. Phosphorylation of osteopontin is required for inhibition of vascular smooth muscle cell calcification. J Biol Chem. 2000; 275: 20197-20203.
27. O'Brien ER, Garvin MR, Stewart DK et al. Osteopontin is synthesized by macrophage, smooth muscle, and endothelial cells in primary and restenotic human coronary atherosclerotic plaques. Arterioscler Thromb. 1999; 14: 1648-1656.
28. Cozzolino M, Brancaccio D, Gallieni M. Slatopolsky E. Pathogenesis of vascular calcification in chronic kidney disease. Kidney Int. 2005; 68: 429-436.
29. Ducy P, Zhang R, Geoffroy V et al. Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell. 1997; 89: 747-754.
30. Reynolds JL, Joannides AJ, Skepper JN et al. Human vascular smooth muscle cells undergo vesicle-mediated calcification in response to changes in extracellular calcium and phosphate concentrations: a potential mechanism for accelerated vascular calcification in ESRD. J Am Soc Nephrol. 2004; 15: 2857-2867.